A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression

• Published in: Alzheimer's & dementia Vol. 13; no. 6; pp. 663 - 673
• Main Authors: Carrasquillo, Minerva M, Allen, Mariet, Burgess, Jeremy D, Wang, Xue, Strickland, Samantha L, Aryal, Shivani, Siuda, Joanna, Kachadoorian, Michaela L, Medway, Christopher, Younkin, Curtis S, Nair, Asha, Wang, Chen, Chanana, Pritha, Serie, Daniel, Nguyen, Thuy, Lincoln, Sarah, Malphrus, Kimberly G, Morgan, Kevin, Golde, Todd E, Price, Nathan D, White, Charles C, De Jager, Philip L, Bennett, David A, Asmann, Yan W, Crook, Julia E, Petersen, Ronald C, Graff-Radford, Neill R, Dickson, Dennis W, Younkin, Steven G, Ertekin-Taner, Nilüfer
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.06.2017
• Subjects: Aged; Aged, 80 and over; Alzheimer Disease - genetics; Alzheimer Disease - metabolism; Alzheimer's disease; Cerebellum - metabolism; eQTL; Female; Gene Expression; Genetic Predisposition to Disease; Genetic Variation; Humans; Linkage Disequilibrium; Male; Membrane Glycoproteins - genetics; Membrane Glycoproteins - metabolism; Microarray Analysis; Multigene Family; Neurology; Quantitative Trait Loci; Receptors, Immunologic - genetics; Receptors, Immunologic - metabolism; Regulatory variant; Temporal Lobe - metabolism; TREM2; TREML1; TREML1; Regulatory variant; TREM2; eQTL; Alzheimer's disease
• ISSN: 1552-5260; 1552-5279; 1552-5279
• DOI: 10.1016/j.jalz.2016.10.005

Abstract Introduction We hypothesized that common Alzheimer's disease (AD)-associated variants within the triggering receptor expressed on myeloid ( TREM ) gene cluster influence disease through gene expression. Methods Expression microarrays on temporal cortex and cerebellum from ∼400 neuropathologically diagnosed subjects and two independent RNAseq replication cohorts were used for expression quantitative trait locus analysis. Results A variant within a DNase hypersensitive site 5′ of TREM2 , rs9357347-C, associates with reduced AD risk and increased TREML1 and TREM2 levels (uncorrected P  = 6.3 × 10−3 and 4.6 × 10−2 , respectively). Meta-analysis on expression quantitative trait locus results from three independent data sets ( n  = 1006) confirmed these associations (uncorrected P  = 3.4 × 10−2 and 3.5 × 10−3 , Bonferroni-corrected P  = 6.7 × 10−2 and 7.1 × 10−3 , respectively). Discussion Our findings point to rs9357347 as a functional regulatory variant that contributes to a protective effect observed at the TREM locus in the International Genomics of Alzheimer's Project genome-wide association study meta-analysis and suggest concomitant increase in TREML1 and TREM2 brain levels as a potential mechanism for protection from AD.